Medicine and Dentistry
Cystic Fibrosis
100%
Therapeutic Procedure
57%
Lung
52%
Patient
45%
Inpatient
41%
Patient with Cystic Fibrosis
39%
Combination Therapy
27%
Syndrome
25%
Pseudomonas aeruginosa
25%
Child
21%
Infant
18%
Silo-Filler's Disease
15%
Airway Obstruction
14%
Forced Expiratory Volume
14%
Scoring System
12%
Placebo
11%
Outpatient
11%
Symptom
11%
Deterioration
10%
Age
10%
Heart Left Ventricle Filling
10%
Azithromycin
10%
Pulmonary Valve
10%
Doppler Echocardiography
10%
Pancrelipase
10%
Gene Expression
10%
Continuous Positive Airway Pressure
10%
Obstructive Sleep Apnea
10%
Ciprofloxacin
10%
Tobramycin
10%
Emphysema
10%
Pediatrics
10%
Stent
10%
Malabsorption
10%
Tetralogy of Fallot
10%
Biological Product
10%
Exocrine Pancreatic Insufficiency
10%
Ceftazidime
10%
Adult
10%
Family
10%
Macrophage
10%
Lung Function
8%
Anti-biotics
7%
Health
7%
Self Esteem
7%
Adverse Event
7%
Follow up
7%
Breathing
6%
Absence
6%
Polarization
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
82%
Pseudomonas aeruginosa
25%
Cystic Adenomatoid Malformation
10%
Dornase Alfa
10%
Pancrelipase
10%
Ciprofloxacin
10%
Exocrine Pancreatic Insufficiency
10%
Malabsorption
10%
Ceftazidime
10%
Tobramycin
10%
Adverse Event
7%
Nitrogen
5%
Fat
5%
Aminoglycoside
5%
Antibiotics
5%
Nursing and Health Professions
Cystic Fibrosis
32%
Ceftazidime
20%
Patient
12%
Family
10%
Patient with Cystic Fibrosis
10%
Cefepime
10%
Pharmacist
10%
Ciprofloxacin
10%
Tobramycin
10%
Biological Product
10%
Inpatient
10%
Pediatrics
10%
Combination Therapy
10%
Depression
10%
Deterioration
7%
